MiMedx Group Inc. Daily Stock Analysis

Daily Stock Analysis, MDXG, MiMedx Group Inc, priceseries

MiMedx Group Inc. Daily Stock Analysis
Stock Information
Open
4.90
Close
4.83
High
4.96
Low
4.71
Previous Close
4.87
Daily Price Gain
-0.04
YTD High
6.35
YTD High Date
Jan 5, 2022
YTD Low
4.12
YTD Low Date
Feb 24, 2022
YTD Price Change
-1.44
YTD Gain
-22.97%
52 Week High
15.99
52 Week High Date
Sep 9, 2021
52 Week Low
4.12
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-5.09
52 Week Gain
-51.31%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 23. 2017
8.92
Apr 26. 2017
11.11
23 Trading Days
24.50%
Link
LONG
Apr 27. 2017
11.40
May 17. 2017
14.50
14 Trading Days
27.18%
Link
LONG
Jan 16. 2018
13.94
Feb 2. 2018
16.38
13 Trading Days
17.50%
Link
LONG
Apr 13. 2018
6.97
May 2. 2018
7.78
13 Trading Days
11.62%
Link
LONG
Jul 23. 2018
3.83
Jul 27. 2018
4.07
4 Trading Days
6.33%
Link
LONG
Dec 31. 2018
1.79
Feb 27. 2019
2.91
39 Trading Days
62.41%
Link
LONG
Mar 14. 2019
3.10
Mar 20. 2019
3.26
4 Trading Days
5.16%
Link
LONG
May 29. 2019
3.33
Jun 11. 2019
4.67
9 Trading Days
40.15%
Link
LONG
Nov 26. 2019
6.43
Dec 10. 2019
6.93
9 Trading Days
7.79%
Link
LONG
Aug 12. 2020
6.22
Sep 1. 2020
6.62
14 Trading Days
6.49%
Link
LONG
Dec 14. 2020
6.50
Dec 28. 2020
8.82
9 Trading Days
35.65%
Link
LONG
Mar 30. 2021
10.08
Apr 16. 2021
11.51
12 Trading Days
14.20%
Link
LONG
May 21. 2021
9.65
Jun 22. 2021
11.59
21 Trading Days
20.08%
Link
LONG
Oct 12. 2021
6.13
Oct 26. 2021
6.65
10 Trading Days
8.53%
Link
LONG
Nov 2. 2021
7.03
Nov 15. 2021
7.94
9 Trading Days
12.93%
Link
Company Information
Stock Symbol
MDXG
Exchange
NasdaqCM
Company URL
http://www.mimedx.com
Company Phone
678-384-6720
CEO
Parker H. Petit
Headquarters
Georgia
Business Address
1775 W OAK COMMONS COURT, NE, MARIETTA, GA 30062
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001376339
About

MiMedx Group, Inc. engages in the designing, manufacturing, and marketing of regenerative biomaterials products and tissue processing services for the wound care, surgical, sports medicine, ophthalmic and dental market categories. Its allograft product families include dHACM family with AmnioFix, EpiFix and EpiBurn brands; Amniotic Fluid family with OrthoFlo brand; Umbilical family with EpiCord™ and AmnioCord brands; Placental Collagen family with CollaFix and AmnioFill brands; Bone family with Physio brand; and Skin family with AlloBurn brand. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Description

MiMedx Group, Inc. develops, processes, and markets patent protected and proprietary regenerative biomaterial products and bioimplants processed from human placental tissue, skin, and bone. The company collects the donated human placental tissue and converts into a sterile product through its proprietary PURION process. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading